Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
A significantly higher proportion of cases compared to controls had abnormal laboratory parameters at the time of admission, except for blood group, creatinine kinase and vitamin D. (Table 3).
Source: Results. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Case-control study.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Determinants of severity among hospitalised COVID-19 patients: Hospital-based case-control study, India, 2020
Source: Article title.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Determinants of severity among hospitalised COVID-19 patients: Hospital-based case-control study, India, 2020
Case-control study · PLoS ONE · 2021
Original publication title
Determinants of severity among hospitalised COVID-19 patients: Hospital-based case-control study, India, 2020
© 2021 Zodpey et al
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Risk factors for the development of severe COVID-19 disease and death have been widely reported across several studies. Knowledge about the determinants of severe disease and mortality in the Indian context can guide early clinical management.
Source: BackgroundAbstract: What methods does the paper describe?
We conducted a hospital-based case control study across nine sites in India to identify the determinants of severe and critical COVID-19 disease.
Source: MethodsAbstract: Findings
We identified age above 60 years, duration before admission >5 days, chronic kidney disease, leucocytosis, prothrombin time > 14 sec, serum ferritin >250 ng/mL, d-dimer >0.5 ng/mL, pro-calcitonin >0.15 μg/L, fibrin degradation products >5 μg/mL, C-reactive protein >5 mg/L, lactate dehydrogenase >150 U/L, interleukin-6 >25 pg/mL, NLR ≥3, and deranged liver function, renal function and serum electrolytes as significant factors associated with severe COVID-19 disease.
Source: FindingsAbstract: Interpretation
We have identified a set of parameters that can help in characterising severe COVID-19 cases in India. These parameters are part of routinely available investigations within Indian hospital settings, both public and private. Study findings have the potential to inform clinical management protocols and identify patients at high risk of severe outcomes at an early stage.
Source: InterpretationAuthors’ abstract
Background
Risk factors for the development of severe COVID-19 disease and death have been widely reported across several studies. Knowledge about the determinants of severe disease and mortality in the Indian context can guide early clinical management.
Methods
We conducted a hospital-based case control study across nine sites in India to identify the determinants of severe and critical COVID-19 disease.
Findings
We identified age above 60 years, duration before admission >5 days, chronic kidney disease, leucocytosis, prothrombin time > 14 sec, serum ferritin >250 ng/mL, d-dimer >0.5 ng/mL, pro-calcitonin >0.15 μg/L, fibrin degradation products >5 μg/mL, C-reactive protein >5 mg/L, lactate dehydrogenase >150 U/L, interleukin-6 >25 pg/mL, NLR ≥3, and deranged liver function, renal function and serum electrolytes as significant factors associated with severe COVID-19 disease.
Interpretation
We have identified a set of parameters that can help in characterising severe COVID-19 cases in India. These parameters are part of routinely available investigations within Indian hospital settings, both public and private. Study findings have the potential to inform clinical management protocols and identify patients at high risk of severe outcomes at an early stage.
Publication and source details
Original title: Determinants of severity among hospitalised COVID-19 patients: Hospital-based case-control study, India, 2020
Sanjay P. Zodpey; Himanshu Negandhi; Vineet Kumar Kamal; Tarun Bhatnagar; Parasuraman Ganeshkumar; Arvind Athavale; Amiruddin Kadri; Amit Patel; A. Bhagyalaxmi; Deepak Khismatrao; E. Theranirajan; Getrude Banumathi; Krishna Singh; P. Parameshwari; Prasita Kshirsagar; Rita Saxena; Sanjay G. Deshpande; Kadloor Satyanand; Saurabh Hadke; Simmi Dube; Sudarshini Subramaniam; Surabhi Madan; Swapnali Kadam; Tanu Anand; Kathiresan Jeyashree; Manickam Ponnaiah; Manish Rana; Manoj V. Murhekar; DCS Reddy
PLoS ONE · 2021
Competing Interests: The authors have declared that no competing interests exist.
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-12T10:40:26.439498+00:00
DOI: 10.1371/journal.pone.0261529 · PMC8716035